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ABSTRACT
Objective: To evaluate the technique of uterine transplantation and the 
use of drugs used in the process of immunosuppression. Methods: 
We included 12 sows, and immunosuppression was performed with 
minimal doses of cyclosporine, and cross-match was done to exclude 
the possibility of blood incompatibility. Hysterectomy was performed 
in the donor under general anesthesia, with the removal of the 
aorta and inferior vena cava in monobloc, and anastomosis of these 
vessels was made in the recipient. Results: Six experiments were 
performed, and on the immediate postoperative period, five animals 
had good reperfusion. However, on the seventh postoperative day, 
histological analysis showed rejection in five animals. Conclusion: 
The experimental model of uterine transplantation is feasible, but 
monitoring doses of immunosuppressants is pivotal to prevent 
rejection episodes.
Keywords: Transplantation; Uterus/transplantation; Infertility; Pregnancy; 
Swine; Models, animal; Immunosuppressive agents; Cyclosporine 
RESUMO
Objetivo: Avaliar a técnica de transplante uterino e o uso de drogas no 
processo de imunossupressão. Métodos: Foram incluídas 12 porcas, 
sendo realizada imunossupressão com doses mínimas de ciclosporina, 
e prova cruzada para afastar a possibilidade de incompatibilidade 
sanguínea. Realizou-se, na doadora, histerectomia sob anestesia geral, 
com a retirada, em monobloco, da aorta e da veia cava inferior, de 
tal forma que, na receptora, fosse possível realizar a anastomose com 
estes vasos. Resultados: Foram realizados seis experimentos e, no 
pós-operatório imediato, houve boa reperfusão em cinco animais. 
Entretanto, no sétimo dia de pós-operatório, as análises histológicas 
demonstraram rejeição em cinco deles. Conclusão: O modelo 
experimental de transplante uterino é factível, mas a monitorização 
das doses de imunossupressores é importante, a fim de impedir os 
episódios de rejeição.
Descritores: Transplante; Útero/transplante; Infertilidade; Gravidez; 
Suínos; Modelos animais; Imunossupressores; Ciclosporina
INTRODUCTION
Recent advancements of Reproductive Medicine, 
especially in some technical aspects, such as hormonal 
stimulation, in vitro fertilization (IVF), and the 
intracytoplasmic sperm injection (ICSI), made it 
possible to solve many causes of male and female 
infertility.(1) For those women with absolute infertility, 
the traditional options of maternity are adoption or 
surrogate pregnancy.(2)
However, in many countries, surrogate pregnancy is 
not accepted due to legal, ethical and religious issues.(3) 
Thus, women submitted to hysterectomy when young 
due to malignant gynecological diseases or benign 
conditions, such as leiomyoma, endometriosis, and 
adenomyosis; patients with significant blood loss after 
a delivery resulting in hysterectomy, and finally, women 
with congenital anomalies of the genital tract, such 
as the Mayer-Rokitansky-Küster-Hauser syndrome, are 
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condemned to not bearing children. Unquestionably, 
for many women this perspective affects their quality 
of life very negatively.(4-7) 
The diverse issues related to surrogate pregnancy 
have led these women to ‘dream’ of the possibility of 
a uterine transplant that would relieve the anguish of 
the immense desire to conceive and bear a child.(8)
Uterine transplant mimicks a normal situation, with 
the primary constituent of genetic, gestational, and 
legal maternity. Additionally, the usual health risks 
associated with pregnancy, such as thromboembolism, 
hypertension, diabetes, and delivery complications, 
would be related to the genetic mother, and not to the 
surrogate mother.(2) 
Over the last years, many advances in organ 
transplants have been reached. Techniques of 
microvascular anastomosis and antirejection drugs are 
becoming safe.(9) Transplantation of non-vital organs, 
like face and hands, has been reported.(10) Nevertheless, 
despite the advances mentioned, uterine transplant is 
still a controversial topic.(9) 
In 2009, the Committee for the Ethical Aspects 
of Human Reproduction and Women’s Health of the 
International Federation of Gynecology and Obstetrics 
(FIGO) prepared a document that established the 
guidelines for uterine transplants in humans. According 
to FIGO, considering the prevalence of female infertility 
due to uterine factors of about 3 to 5% and the issues that 
involve surrogate gestation, in these specific situations 
a transplant is justified.(11) However, any procedure 
in humans would only be justified after trials carried 
out in adequate animal models, which should include 
primates, due to the similarity of anatomical structures 
with those of the human species.(11)
OBJECTIVE
To evaluate the technique of uterine transplant and the 
drugs used in the process of immunosuppression in an 
animal model. 
METHODS
This study was performed by means of a partnership 
between the Universidade Federal de São Paulo 
(UNIFESP), registered and approved by the Research 
Ethics Committee under number 2112/08, and the 
Instituto Israelita de Ensino e Pesquisa Albert Einstein 
(IIEP), registered and approved by Research Ethics 
Committee under number CEUA 1074-09. During 
the period between April 2009 and April 2011, six 
experiments were performed (12 operations) at the 
Surgical Experimentation and Training Center (CETEC - 
Centro de Experimentação e Treinamento em Cirurgia) of 
Hospital Israelita Albert Einstein (HIAE). All activities 
at CETEC followed the ethical procedures and the best 
practices in treatment and in their use in animals. 
Twelve Large White sows, aged 8-13 months and 
weight varying between 30 and 40kg were included. 
Crossmatch was performed to rule out the possibility 
of blood incompatibility of the animals - donors and 
recipients. 
Procedures in the donor and in the recipient
The anesthesia protocol for swine consists of solid and 
fluid fasting for approximately 12 hours. In the bays, 
the animals received the pre-anesthetic medications: 
ketamine hydrochloride in bolus of 10mg/kg associated 
with midazolam 0.25mg/kg, via intramuscular injection 
in the buttocks. After five minutes, the sows were 
showered to remove dirt and debris from the body; 
then they were weighed and sent to the operating room 
(Table 1).
Table 1. Weight of donors and recipients
Experiment Donor weight (kg) Recipient weight (kg)
1 29.6 33.5
2 28 29
3 30 36
4 25 28
5 26 28
6 27 24
The peripheral veins of the animals were punctured 
with Jelco 22, and anesthetic induction was done with 
etomidate (1 to 2mg/kg=15mL). After relaxation as 
soon as the eyes showed rotation, the animals were 
intubated with a 6.5 orotracheal tube. Anesthesia was 
maintained with 1.5% isoflurane gas diluted in 2 liters 
of oxygen, with a tidal volume of 10mL/kg/hour. Before 
beginning the surgical procedure, analgesics and muscle 
relaxants were applied. Analgesic administration was 
done with fentanyl 2.5mcg/kg, and the muscle relaxants 
used were cisatracurium besylate, at 0.24mg/kg, and 
pancuronium at 0.2mg/kg. 
Electrodes and an oximeter were placed on the 
animals to monitor them during the entire procedure. 
Asepsis and antisepsis were done on the abdominal and 
inguinal regions.
Immunosuppression was performed as shown on 
table 2.
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The donor and recipient animals were submitted 
to the following procedures: asepsis of the skin with a 
degerming agent, povidone-iodine (PVP-I), positioning 
of the sterile surgical drapes, median xipho-pubic 
incision of the skin, opening of the subcutaneous tissue, 
and hemostasis; opening of aponeurosis, visualization 
of abdominal cavity, inspection of organs, and dissection 
of the peritoneum until identification of the aorta and 
inferior vena cava. 
In the donor, the following technique was used: 
ligation of the dorsal branches of the aorta with cotton 
3.0; dissection of the retroperitoneum until identification 
of the external iliac arteries bilaterally; dissection of 
the broad ligament until isolation of the uterine horn, 
ligation of the ureter at the insertion of the bladder, 
caudal dissection of the internal iliac artery until the 
origin of the uterine artery, followed by ligation of the 
iliac vessels, from the vaginal branch of the internal iliac 
artery bilaterally, of the versicouterine ligament and 
uterine vessels bilaterally with cotton 2.0, and of the 
pelvic infundibular ligaments; preparation of a solution 
with 0.9% saline at room temperature and 0.9% frozen 
saline, maintaining the solution at 4°C; catheterization 
of the external iliac artery with temporary urinary 
catheter number 14; ligation of the aorta; infusion of 
the Collins solution through the catheter of the external 
iliac artery until complete cleansing of the circulation 
to the uterus; sectioning of the inferior vena cava to 
euthanize the animal; ligation of the external iliac artery 
bilaterally; sectioning of the vagina at the uterine cervix; 
removal of the uterus and its preservation in the frozen 
saline; and closure of the donor cavity with Vicryl-0 in 
continuous suture (Figures 1 and 2). 
The recipient was submitted to the following 
technique: repair of the proximal and distal vessels with 
the aid of cotton sutures 2.0, and grasping the inferior 
vena cava using the Satinsky vascular clamps, followed 
by its sectioning. Later, termino-lateral anastomosis 
was performed with the vena cava from the graft, and 
continuously sutured with Prolene 7.0 and Satinsky 
clamps. The aorta was grasped and then sectioned, and 
termino-lateral anastomosis was made with the aorta 
from the graft,and continuously sutured with Prolene 
7.0. Reperfusion and hemostatic review of the graft were 
done, with anastomosis of the donor’s vaginal cavity and 
the recipient using Vicryl 4.0, synthesis of the aponeurosis 
with Vicryl 1.0, and synthesis of the skin with Vicryl 1.0 
using interrupted sutures (Table 3 and Figure 3).
Table 2. Dose of cyclosporine administered per day
Day Event Route Dose (mg/kg/day)
D1 Transoperative Intravenous 2
D2 Transoperative Intravenous 2
D3 Postoperative Oral 5
D4 Postoperative Oral 5
D5 Postoperative Oral 5
D6 Postoperative Oral 5
D7 Postoperative Oral 5
D8 Postoperative Oral 5
D9 Postoperative Oral 5
D10 Postoperative Oral 5
D11 Postoperative Oral 5
D12 Postoperative Oral 5
D13 Postoperative Oral 5
D14 Postoperative Oral 5
Figure 1. Donor uterus
Figure 2. Final aspect of the transplanted heterotopic uterus
Figure 3. Final aspect of the transplanted heterotopic uterus
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Chart 1. Histological aspect of the uterus
Experiment Vitality of the graft Histological aspect 
1 Excelente Absence of rejection
2 Excelente Acute rejection
3 Excelente Acute rejection
4 Ausente Hyperacute rejection 
5 Excelente Acute rejection
6 Excelente Acute rejection
Table 3. Control of surgery in the recipient
Experiment Start of anesthesia Start of surgery Clamping Start of anastomosis Reperfusion Heparinization End of procedure
1 12:40pm 12:50pm 1:00pm 1:05pm 1:45pm 1:45pm 2:15pm
2 1:20pm 1:35pm 2:00pm 2:05pm 3:10pm 3:10pm 4:30pm
3 1:40pm 1:50pm 2:00pm 2:05pm 2:45pm 2:45pm 3:15pm
4 11:40am 11:50am noon 12:05pm 12:45pm 12:45pm 1:15pm
5 noon 12:24pm 1:00pm 1:05pm 1:45pm 1:45pm 2:50pm
6 12:40pm 12:50pm 1:00pm 1:05pm 1:45pm 1:45pm 2:15pm
RESULTS
After reanastomosis, vitality of the graft (reperfusion) 
was evaluated. In five recipients, except in the animal 
of the fourth experiment, the recipients were followed 
up daily, for seven days. On the seventh postoperative 
day, the five animals were sent for laparotomy, which 
followed the same anesthetic care already described. 
After opening the cavity, necrosis of the implanted 
uterus was observed. At this time, the implanted organ 
was collected and the animals were euthanized, and then 
sent to the freezer for posterior incineration. In the 
animal of the fourth experiment, after reanastomosis, 
the absence of graft vitality was observed (poor 
reperfusion). Next, the implanted organ was collected 
and the animal was euthanized and sent to the freezer 
for posterior incineration.
Histological evaluations of the implanted uteri 
were made. In the first experiment, necrosis was 
demonstrated by a likely mechanical component and 
the absence of signs of rejection. In the second, third, 
fifth, and sixth experiments, necrosis was demonstrated 
by acute rejection (presence of inflammatory infiltrate 
with glandular aggression and capillaritis, especially by 
neutrophils). Necrosis by hyperacute rejection (presence 
of inflammatory infiltrate with extreme glandular 
damage and capillaritis, especially by neutrophils) was 
noted in the animal of the fourth experiment (Chart 1).
remained in the recipient for 99 days, when occlusion 
of the uterine vessels occurred due to thrombosis.(8) 
In Turkey, in 2011, a 21-year-old patient born with no 
a uterus received the first uterine transplant from a 
deceased donor. The preliminary results of this procedure 
were published in 2013 and did not reveal rejection to 
the graft.(12) 
The Swedish group of Dr. Mats Bräannström has 
a line of research on uterine transplants in live donors. 
This group performed nine uterine transplants and did 
not report any immediate postoperative complications. 
It was recorded that, after six months, seven patients 
had a viable graft, and two lost the graft due to 
thrombotic phenomena.(13) The group considers that, 
unlike any other type of transplant, the uterine graft is 
transient, that is, it is removed as soon as the desired 
result is reached, i.e., one or two healthy gestations. 
Thus, immunosuppression is done for a limited period. 
In their studies with animal models, the members of 
the group assured that, the procedure is compatible 
with fully normal gestations, even when women are on 
immunosuppression.(13)
In our research, we used a minimal dose of 
cyclosporine, and this probably led to a high frequency 
of rejection. Additionally, we did not control the 
serum levels of the immunosuppressant, which might 
have had an expressive negative contribution in this 
aspect. Our results differ from those of the project by 
Avison et al., who described the first model of uterine 
transplant in swine and concluded that such model is 
feasible in heterotopic transplants.(14) Immunosuppression 
was carried out with intravenous tacrolimus during the 
first 12 days after transplant, followed by maintenance 
immunosuppression with oral cyclosporine. Acute graft 
rejections during the second and third post-transplant 
months were treated successfully with increased 
maintenance immunosuppression and steroids.(14)
Unlike other organs supplied by large-diameter 
vessels, the uterus receives blood from a network of 
small-diameter vessels. This means that establishing 
blood flow to a transplanted organ is extremely complex 
DISCUSSION
The first human uterine transplant was performed in 
Saudi Arabia, in 2000. However, the transplanted uterus 
485Description and evaluation of experimental models for uterine transplantation in pigs
einstein. 2017;15(4):481-5
and prone to problems. We began our project with 
the model in rabbits. However, right away in the first 
procedures we identified the need for a change in 
animal model. Rabbits are stressed and fragile animals, 
with very small blood vessels. Therefore, we chose to 
work with a swine model. Additionally, vessels that 
supply blood to the uterus should be able to expand up 
to three times during gestation in order to sustain the 
development of the fetus. 
CONCLUSION
Unquestionably, our work is an arduous and complex 
task. In Brazil, it is a pioneer project. We were successful 
in performing the operative technique, but realized that 
it is necessary to have rigorous observation and control 
of immunosuppressant levels. Our results suggest that 
drugs that are more modern should be used in the 
process of immunosuppression. Further studies should 
be conducted, so that there is progress in this fascinating 
field of knowledge, which can improve the quality of life 
of many women. 
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